Search results
Oral nucleoside antiviral is progressing toward future pandemic preparedness
Medical Xpress· 21 hours agoSeveral researchers at the University of North Carolina at Chapel Hill's Gillings School of Global...
Scientists Race To Perfect New Oral COVID-19 Treatment Poised To Replace Paxlovid
SciTechDaily· 2 days agoRutgers researchers are advancing a potential new COVID-19 treatment, Jun12682, which is effective in animal studies and compatible with other medications, unlike the current leading treatment ...
CAR T-Cell Therapy Could Be A Gamechanger For Autoimmune Diseases
Forbes· 6 days agoA recent study in the New England Journal of Medicine grabbed the attention of the medical community...
Invivyd appoints new Chief Commercial Officer ahead of PEMGARDA launch By Investing.com
Investing.com· 4 days agoInvivyd, Inc. (NASDAQ:IVVD), a company focused on developing treatments for viral infectious...
Fauci Denies 'False Accusation' of COVID Origins Cover-Up
MedPage Today· 2 days agoHouse Republicans grilled Anthony Fauci, MD, former chief medical adviser to President Biden, during a contentious House hearing on Monday, but Fauci was adamant that accusations about his involvement ...
Column: Anatomy of a smear — Fauci faces the House GOP's clown show about COVID
AOL· 8 hours agoHere's what we know about Dr. Anthony S. Fauci: As a staff member at the National Institutes of Health for 54 years and director of its National Institute for Allergy and Infectious Diseases ...
Medications to Treat Upper Respiratory Infections
Healthline· 6 days agoMedications such as nasal decongestants and cough suppressants may help manage symptoms of upper respiratory infections. A respiratory infection affects...
Invivyd aligns with FDA on rapid mAb trial pathway By Investing.com
Investing.com· 4 days agoInvivyd Inc. (NASDAQ: IVVD), a biopharmaceutical company, has announced an agreement with the U.S....
